[Recurrences of lymphoblastic leukemia in children. II. Prognosis and treatment]

Twenty years of Polish experience with three consecutive protocols for treatment of childhood acute myelogenous leukemia.

Leukemia·2005

[Abdominal presentation of B-cell non-Hodgkin's lymphoma (B-NHL) - surgical treatment and its results. Report of the Polish Paediatric Leukaemia/Lymphoma Study Group].

Medycyna wieku rozwojowego·2002

[Implementation of a psychological support program for children with cancer in Poland. Preliminary report].

Medycyna wieku rozwojowego·2002

[Preliminary results of BFM 96 protocol in treatment of childhood ALL relapse in the experience of the Polish Paediatric Leukaemia /Lymphoma Study Group].

Medycyna wieku rozwojowego·2002

[High risk acute lymphoblastic leukaemia in children. Preliminary report after introducing a new version of New York (1997) protocol adjusted to the age of the patients. Report of the Polish Paediatric Leukaemia/Lymphoma Study Group].

Medycyna wieku rozwojowego·2002

[G-CSF and GM-CSF in treatment of neutropaenia after chemotherapy in children with neoplasms].

Medycyna wieku rozwojowego·2002

Monoclonal antibodies for prophylactic and therapeutic use against viral infections.

Pediatria polska·2020

[Barriers in breast feeding: contraindications].

Pediatria polska·1996

[Echinococcosis infection in three children].

Pediatria polska·1996

[Newborn baby with extreme acidosis].

Pediatria polska·1996

[Adult stature prediction in boys according to the Khamis-Roche method and proposed regression equations].

Pediatria polska·1996

[Serum prolactin concentration in children with celiac disease].

Pediatria polska·1996

Exploring the Expanding Role of Nuclear Receptor LRH-1/NR5A2 in Cell Biology and Immunity.

International journal of cell biology·2026

Cuproptosis-related molecular alterations in a neonatal rat model of hypoxic-ischemic brain damage.

Frontiers in neurology·2026

Off-Target MAP2K7 Inhibition Drives the Antileukemic Activity of the PD-1/PD-L1 inhibitor ACS-69 in Pediatric T-ALL.

Research square·2026

A CRISPR-Cas9 platform for primary human hepatocytes enables arrayed screening and in vivo validation of HBV host factors.

bioRxiv : the preprint server for biology·2026

Myeloid differentiation-associated autophagy drives venetoclax resistance in AML.

Research square·2026

Structure of full-length APOBEC3B bound to EBV BORF2 reveals coordinated neutralization of a cancer-associated mutator.

Research square·2026

Related Experiment Videos

[Recurrences of lymphoblastic leukemia in children. II. Prognosis and treatment]

Related Concept Videos

Twenty years of Polish experience with three consecutive protocols for treatment of childhood acute myelogenous leukemia.

[Abdominal presentation of B-cell non-Hodgkin's lymphoma (B-NHL) - surgical treatment and its results. Report of the Polish Paediatric Leukaemia/Lymphoma Study Group].

[Implementation of a psychological support program for children with cancer in Poland. Preliminary report].

[Preliminary results of BFM 96 protocol in treatment of childhood ALL relapse in the experience of the Polish Paediatric Leukaemia /Lymphoma Study Group].

[High risk acute lymphoblastic leukaemia in children. Preliminary report after introducing a new version of New York (1997) protocol adjusted to the age of the patients. Report of the Polish Paediatric Leukaemia/Lymphoma Study Group].

[G-CSF and GM-CSF in treatment of neutropaenia after chemotherapy in children with neoplasms].

Monoclonal antibodies for prophylactic and therapeutic use against viral infections.

[Barriers in breast feeding: contraindications].

[Echinococcosis infection in three children].

[Newborn baby with extreme acidosis].

[Adult stature prediction in boys according to the Khamis-Roche method and proposed regression equations].

[Serum prolactin concentration in children with celiac disease].

Exploring the Expanding Role of Nuclear Receptor LRH-1/NR5A2 in Cell Biology and Immunity.

Cuproptosis-related molecular alterations in a neonatal rat model of hypoxic-ischemic brain damage.

Off-Target MAP2K7 Inhibition Drives the Antileukemic Activity of the PD-1/PD-L1 inhibitor ACS-69 in Pediatric T-ALL.

A CRISPR-Cas9 platform for primary human hepatocytes enables arrayed screening and in vivo validation of HBV host factors.

Myeloid differentiation-associated autophagy drives venetoclax resistance in AML.

Structure of full-length APOBEC3B bound to EBV BORF2 reveals coordinated neutralization of a cancer-associated mutator.

Related Experiment Videos

[Recurrences of lymphoblastic leukemia in children. II. Prognosis and treatment]

Related Concept Videos

Related Articles